Denali Advisors LLC Grows Position in HCA Healthcare, Inc. (NYSE:HCA)

Denali Advisors LLC boosted its holdings in HCA Healthcare, Inc. (NYSE:HCA) by 78.6% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 2,500 shares of the company’s stock after purchasing an additional 1,100 shares during the quarter. Denali Advisors LLC’s holdings in HCA Healthcare were worth $750,000 at the end of the most recent quarter.

A number of other institutional investors also recently bought and sold shares of the business. Todd Asset Management LLC grew its position in HCA Healthcare by 1.7% in the 4th quarter. Todd Asset Management LLC now owns 136,917 shares of the company’s stock valued at $41,096,000 after buying an additional 2,348 shares during the last quarter. Keeler Thomas Management LLC acquired a new stake in HCA Healthcare in the fourth quarter valued at $797,000. IFP Advisors Inc grew its stake in shares of HCA Healthcare by 23.2% during the 4th quarter. IFP Advisors Inc now owns 9,444 shares of the company’s stock worth $2,835,000 after purchasing an additional 1,777 shares during the period. Y Intercept Hong Kong Ltd lifted its stake in shares of HCA Healthcare by 209.0% in the fourth quarter. Y Intercept Hong Kong Ltd now owns 18,587 shares of the company’s stock valued at $5,579,000 after purchasing an additional 12,571 shares during the period. Finally, Union Bancaire Privee UBP SA purchased a new position in HCA Healthcare in the fourth quarter valued at about $1,060,000. 62.73% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of equities research analysts recently weighed in on the company. JPMorgan Chase & Co. restated a “neutral” rating and issued a $380.00 price target on shares of HCA Healthcare in a report on Tuesday, December 17th. StockNews.com downgraded HCA Healthcare from a “strong-buy” rating to a “buy” rating in a research note on Monday, November 4th. Royal Bank of Canada cut their target price on shares of HCA Healthcare from $405.00 to $384.00 and set an “outperform” rating for the company in a research report on Monday, January 27th. Truist Financial dropped their price objective on shares of HCA Healthcare from $430.00 to $390.00 and set a “buy” rating for the company in a research note on Monday, January 6th. Finally, Cantor Fitzgerald reiterated an “overweight” rating and set a $405.00 target price on shares of HCA Healthcare in a report on Monday, January 27th. One analyst has rated the stock with a sell rating, three have issued a hold rating, thirteen have issued a buy rating and two have assigned a strong buy rating to the company’s stock. According to data from MarketBeat, HCA Healthcare has an average rating of “Moderate Buy” and an average price target of $385.67.

Insiders Place Their Bets

In other news, SVP Jennifer Berres sold 9,533 shares of the company’s stock in a transaction dated Friday, February 14th. The stock was sold at an average price of $322.59, for a total value of $3,075,250.47. Following the completion of the sale, the senior vice president now owns 15,412 shares of the company’s stock, valued at $4,971,757.08. This represents a 38.22 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. 1.60% of the stock is owned by insiders.

HCA Healthcare Stock Down 4.0 %

HCA opened at $319.65 on Thursday. HCA Healthcare, Inc. has a 12 month low of $289.98 and a 12 month high of $417.14. The business has a 50-day moving average of $314.65 and a two-hundred day moving average of $350.12. The stock has a market capitalization of $79.38 billion, a price-to-earnings ratio of 14.55, a price-to-earnings-growth ratio of 1.10 and a beta of 1.64. The company has a debt-to-equity ratio of 69.07, a current ratio of 1.08 and a quick ratio of 0.97.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings results on Friday, January 24th. The company reported $6.22 earnings per share for the quarter, beating analysts’ consensus estimates of $6.03 by $0.19. HCA Healthcare had a net margin of 8.16% and a return on equity of 586.47%. During the same period last year, the firm posted $5.90 EPS. On average, research analysts expect that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Monday, March 31st. Investors of record on Monday, March 17th will be issued a $0.72 dividend. This is a positive change from HCA Healthcare’s previous quarterly dividend of $0.66. The ex-dividend date of this dividend is Monday, March 17th. This represents a $2.88 annualized dividend and a yield of 0.90%. HCA Healthcare’s dividend payout ratio (DPR) is presently 13.11%.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.